Email: cspc@cspc.cn
Media
News Center
Apr. 18
2024
CSPC Won Shijiazhuang Municipal Government Quality Award
CSPC Ranks Among Top 15 Value-leading Chinese Listed Innovative Drug Companies
Mar. 29
Results of a Phase III Clinical Study on Batoclimab of CSPC Published in JAMA Sub-journal
Mar. 25
VOLUNTARY ANNOUNCEMENT - DAPAGLIFLOZIN TABLETS OBTAINS DRUG REGISTRATION APPROVAL
Mar. 21
VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL
Mar. 19
VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039)OBTAINS CLINICAL TRIAL APPROVAL
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us